Trial Profile
A phaseI trial of S-1 Oxaliplatin and Bevacizumab in combination with Radiotherapy for Neoadjuvant Therapy of Locally advanced lower rectal cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Adverse reactions
- 06 Jan 2012 New trial record